missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Phospho-PLCg2 (Tyr759) Recombinant Rabbit Monoclonal Antibody (PLCG2Y759-G3), PE, Invitrogen™

Rabbit Recombinant Monoclonal Antibody
£185.00 - £463.00
Specifications
| Antigen | Phospho-PLCg2 (Tyr759) |
|---|---|
| Clone | PLCG2Y759-G3 |
| Applications | Flow Cytometry |
| Classification | Recombinant Monoclonal |
| Conjugate | PE |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
17196818
|
Invitrogen™
MA537233 |
10 Tests |
£185.00
Pack of 10 |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17166508
![]() |
Invitrogen™
MA536920 |
100 Tests |
£463.00
Pack of 100 |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Phosphoinositide-specific phospholipase C (PLC) plays a crucial role in the initiation of receptor mediated signal transduction through the generation of the two second messengers, inositol 1,4,5-triphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. There are many mammalian PLC isozymes, including PLC beta1, PLC beta2, PLC beta3, PLC beta4, PLC gamma1, PLC gamma2, PLC delta1, PLC delta2 and PLCe. PLC delta exists as four different isoforms. PLC delta1, a calcium signal amplifier, is activated by an atypical GTP-binding protein. In addition, PLC delta1 is an effector for GTP-binding protein transglutaminase II-mediated oxytocin receptor and alpha1B-adrenoreceptor signaling. Mouse PLC delta1 is highly expressed in brain, heart, lung and testis. PLC delta is abnormally accumulated in autopsied brains with Alzheimer's disease (AD), suggesting that it may play a role in the pathology of AD. PLC delta2 is markedly expressed in type II intestinal metaplasia and in the adenocarcinoma. When PLC delta2 is expressed in type I intestinal metaplasia, the metaplasia is generally considered benignant, yet evolves toward neoplastic transformation. Thus, PLC delta2 expression may be a possible marker of gastric malignant transformation.Specifications
| Phospho-PLCg2 (Tyr759) | |
| Flow Cytometry | |
| PE | |
| Rabbit | |
| Human, Mouse | |
| P16885, Q8CIH5 | |
| 234779, 5336 | |
| A synthetic phospho-peptide corresponding to residues surrounding Tyr759 of human phospho PLCg2. | |
| Primary | |
| 4°C | |
| Plcg2 |
| PLCG2Y759-G3 | |
| Recombinant Monoclonal | |
| Liquid | |
| RUO | |
| PBS with 0.20% BSA and 0.09% sodium azide | |
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2; 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2; APLAID; FCAS3; phosphoinositide phospholipase C; phosphoinositide phospholipase C-gamma-2; phospholipase C gamma 2; phospholipase C, gamma 2; phospholipase C, gamma 2 (phosphatidylinositol-specific); phospholipase C-gamma-2; Phospholipase C-IV; PLC gamma 2; PLC gamma2; PLC- gamma2; PLC gamma-2; PLCG2; Plcg-2; PLC-gamma; PLCgamma2; PLC-gamma-2; PLC-IV | |
| Plcg2 | |
| IgG κ | |
| Protein A/G | |
| Antibody |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title